Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.

Slides:



Advertisements
Similar presentations
Diagnosing Tuberculosis Pamela Hepple Medecins Sans Frontieres UK.
Advertisements

Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Improving diagnosis TB laboratory strengthening.
Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.
1 Increasing health system efficiency: Use of motorcycles for patient outreach in Kisumu, Nyanza Province D. O’Farrell 1, K. Nichols 1, K. Harrison 1,
Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
World TB Day 2011 March 24, 2011 Mavuso Centre Manzini – Kingdom of Swaziland.
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Task-Shifting in HIV/AIDS Care in a Rural District of Malawi Some successes and lessons learnt from Thyolo Moses Massaquoi, Rony Zachariah, Ulrike von.
Washington D.C., USA, July 2012www.aids2012.org The value of universal TB screening with GeneXpert MTB/RIF in pre-ART patients in Harare L. Mupfumi.
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
In the name of God Fariba Rezaeetalab Assistant Professor.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
OnSite TB/HIV Ab Rapid Test 2 in 1 test kit
TB Screening in the Antenatal Care Setting in Malawi Symposium: Exploring the intersection between TB and maternal and neonatal health: from research to.
COMPREHENSIVE APPROACH TO TB DIAGNOSIS
Zero TB deaths among PLHIV: what are the gaps and what is missing? Haileyesus Getahun Stop TB Department World Health Organisation, Geneva. Reaching Zero.
Unit 5: IPT Isoniazid TB Preventive Therapy
Standard of Care for MDR-TB
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Integrating HIV and TB services : operational research issues TB/HIV workshop TAC/TAG June 2006 MÉDECINS SANS FRONTIÈRES SOUTH AFRICA UNIVERSITY OF CAPE.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
INTERGRATING TB/HIV DATABASES INTERGRATING TB/HIV DATABASES Presenter: DR. LAMECK DIERO.
Experience establishing TB Laboratory capacity in Lesotho Dr Vollepore FIND.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Isoniazid preventive therapy for people living with HIV: Public health challenges and implementation issues Peter Godfrey-Faussett UNAIDS (with thanks.
British Society for Microbial Technology The laboratory diagnosis of tuberculosis 25 years of progress D A Mitchison St George’s, University of London.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Experience with Tb diagnostics and Scale up of services Botswana, Nigeria, and Tanzania Ernest Ekong, MD,MPH National Clinical Coordinator Harvard PEPFAR.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
HIV/TB Interventions among Migrants in Thailand: A Community-Based Approach Jaruwaree Snidwongse, PhD Global Fund Principal Recipient Manager (TB) World.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Experiences in Tanzania: Community Based Efforts to Support HIV/TB Integration Jackson Mugyabuso Dr. Charlotte Colvin PATH 25 July 2012.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Strengthening National Lab. Network for diagnosis of TB and HIV: Challenges and solutions. Nicholas Wambua MD; MPH; DTCE. Technical Advisor -Tuberculosis.
From operational research to policy and practice The Union, Paris, France MSF, Brussels, Belgium.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
MSF TB Program for Migrants in Tak. Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo,
The role of prevalence surveys in measuring the burden of TB, progress in TB control and improving early case detection Ikushi Onozaki WHO/STB/TBS Global.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
Challenges of ICF among PLHIV and how to move forward G J Churchyard 17 th April th Core Group Meeting of the TB/HIV Working Group New York.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.
TB infection control in the era of MDR and XDR TB Haileyesus Getahun Stop TB Department WHO/HQ.
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
Country Progress Report Cambodia
Scale up of collaborative TB/HIV activities in Kenya
Update on Global Fund ATM
The role of the community in TB control
Engagement of Informal Health Care Providers Increases Referrals and Successful Outcome of TB patients in Tribal District of India Using Mobile Technology.
Buhera District.
South Africa: From ProTest to Nationwide Implementation
Presentation transcript:

Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières

Context MSF support in the Hospital Since 2000 TB program ART program Integrated TB/HIV care TB culture laboratory in 2007 MSF support in the periphery Mobile clinic to 3 health centres Supply drugs 6 month regimen Homa Bay District Rural area 350,000 habitants 30% HIV prevalence

Context HIV patients 13,000 active patients on care 10,000 active patients on ART TB patients 1,500 new TB cases/year in District 400 new TB cases in Chest Clinic 80% HIV/TB co-infected

Methods Mycobacterium culture laboratory Techniques: Thin Layer Agar, Lowenstein-Jensen Routine activity since November 2007 Patients targeted Patients with cough >2 weeks and at least 2 negative sputum smear microscopy Retrospective study Period of the study: 15 th Nov 07 to 25 th July 08

Methods TLA technique: Solid culture (7H11) Petri dish (2 parts: 1 normal media; 1 with PNB) Incubator CO2 Reading with microscope Why this technique was chosen? Less logistics, maintenance, technical problems Lower cost Solid culture – less contamination expected, bio-safety

Comparison Mycobacterium culture techniques LJTLAMGITMODS MediumSolid Liquid Manual/AutomatedMMAM Equipment/Maintenance Time to positive (days) Sensitivity* - Smear Smear – Cost (USD) DST simultaneousNoYesNoYes * Int J Tuberc Lung Dis 10 (6): , Robledo et al

Results Culture result available in 365 patients: 50% negative, 31% positive, 19% contaminated 56% of culture positive had not started treatment Out of the 63 patients traced: 46% found and started on treatment 11% found and referred to the closest TB site 16% had died 13% could not be found 14% were still being traced

Results Patients missed through clinical algorithm and started on treatment after culture: 29 patients = 3.5 patients per month Patients diagnosed through clinical algorithm: 265 = 31.9 patients per month Proportion of TB patients diagnosed through culture: 10.9% Average time to get a positive result: 24 days

Results TLALJ Positive rate13%14% Negative rate62%69% Contamination rate24%17% Time to positive result 16 days26 days Culture results on smear negative samples from Nov 07 to Jul 08

Discussion - Achievements Almost a third of the TB suspect patients with negative smear were found positive by culture More than a half of them had been missed through clinical algorithm Culture had allowed the diagnosis of 11% of the total TB patients Time for positive results long but improving

Discussion - Challenges Cost of the laboratory Contamination rate currently high Electricity: back-up system required Keeping the laboratory clean: change shoes, windows closed, dust coats, etc. Training of the laboratory technicians is long BSC maintenance: technician coming from SA

Discussion - Challenges Expenses for TB culture laboratory (Jan 07-Sept 08) TOTAL expenses : € 17% 30% 25% 28% ConstructionEquipmentConsumableStaff 48,5 K € 83,6 k € 70 k € 77,8 k €

Conclusions Routine culture may have an important impact in the diagnosis of TB in a high HIV prevalence setting Is it cost-effective to set up a culture laboratory in an African rural context? Other alternatives? TLA has a potential in peripheral settings compared with others techniques (MGIT, LJ)